(Q39622428)

13 September 2017

title

Chronic obstructive pulmonary disease and lung cancer: common pathogenesis, shared clinical challenges (English)

1 reference

chronic obstructive pulmonary disease

13 September 2017

main subject

1 reference

1 reference

Bartolome R Celli

1

1 reference

13 September 2017

publication date

1 May 2012

1 reference

Proceedings of the American Thoracic Society

13 September 2017

published in

1 reference

13 September 2017

volume

9

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

74-79

1 reference

Global cancer statistics, 2002

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

21 January 2018

100 years of lung cancer

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Systemic manifestations and comorbidities of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Mortality by cause for eight regions of the world: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Mortality in COPD: Role of comorbidities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Future of cancer incidence in the United States: burdens upon an aging, changing nation

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Genetics and genomics of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Lung cancer and its association with chronic obstructive pulmonary disease: update on nexus of epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Admixture mapping of lung cancer in 1812 African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Epidemiology of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Epigenetic control of gene expression in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Epigenetic regulation of airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

The epigenomics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Altered methylation patterns in cancer cell genomes: cause or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Systems biology and personalized medicine: a network approach to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Characterisation of COPD heterogeneity in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Expression of ABCG2 (BCRP) Is Regulated by Nrf2 in Cancer Cells That Confers Side Population and Chemoresistance Phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Evidence for human lung stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Cellular senescence: putting the paradoxes in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Aging and cancer cell biology, 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Cellular senescence, cancer and aging: the telomere connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

p53: Pro-aging or pro-longevity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Oncogene-induced senescence pathways weave an intricate tapestry

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

MicroRNAs: novel biomarkers for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

A novel p53 mutant retained functional activity in lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Telomere length and the risk of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Telomeres: prognostic markers for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

The tumor suppressor p53: cancer and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

A chitinase-like protein in the lung and circulation of patients with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Plasma YKL-40: a potential new cancer biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

YKL-40--an emerging biomarker in cardiovascular disease and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Genetics of preneoplasia: lessons from lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Profiles in variation: lung carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Genetically informed lung cancer medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

A major step towards individualized therapy of lung cancer with gefitinib: the IPASS trial and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Coadaptation of Helicobacter pylori and humans: ancient history, modern implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Helicobacter pylori genetic diversity and risk of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Helicobacter pylori, asthma and allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Asthma is inversely associated with Helicobacter pylori status in an urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Analysis of the lung microbiome in the "healthy" smoker and in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Human pathogens abundant in the bacterial metagenome of cigarettes

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Lung volumes and emphysema in smokers with interstitial lung abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Sex Differences in Mortality and Clinical Expressions of Patients with Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

Telomere shortening in smokers with and without COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201107-039MS

10.1513/PATS.201107-039MS

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference